CompletedPhase 2

Study for Pre-Surgical Weight Loss in Type II Diabetes Patients

Brazil22 participantsStarted 2008-10

Plain-language summary

The purpose of this study is to determine whether the GI Sleeve is safe and effective in treating Type II diabetes patients

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 to 65 * BMI 40 to 60 * Type II Diabetes * Candidates for bariatric surgery Exclusion Criteria: Patients with * hepatitis B or C * gastroesophageal reflux disease (GERD) * HIV Positive diagnosis * pancreatitis * conditions of gastrointestinal tract, such as ulcers or Crohn's * an infection or who are H. Pylori positive

What they're measuring

% of Excess Weight Loss (EWL)

Timeframe: 12 months

Trial details

NCT IDNCT00791128

SponsorMorphic Medical Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2010-03

Results submitted2016-11-01

View on ClinicalTrials.gov More Type 2 Diabetes trials